Listed

Natural Alternatives International Inc

NAIINasdaqCIK 787253HealthcareFiscal year ends Jun 30

Latest reported revenue, Q4 FY2026$34.5mRevenue, Q4 FY2026, three months to 2026-06-30$34.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figureThree months to Jun 30, 2026, from the 10-K filed Sep 28, 2026.

Latest quarter: Q4 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$34.5mRevenue, Q4 FY2026, three months to 2026-06-30$34.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figure+1.9% on a year earlier
  • Gross margin5.0%Gross margin, Q4 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $1.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Revenue: $34.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figure−5.4 pts on a year earlier
  • Operating margin−38.2%Operating margin, Q4 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$13.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Revenue: $34.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figure−32.4 pts on a year earlier
  • Net margin−39.2%Net margin, Q4 FY2026, three months to 2026-06-30. net income / revenueNet income: −$13.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Revenue: $34.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figure−17.9 pts on a year earlier
  • Diluted EPSnot reported (Diluted EPS not reported)No year-earlier figure to compare
  • Free cash flow−$1.7mFree cash flow, Q4 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Capital expenditure: $637.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figureSign changed from a year earlier

Last eight quarters

Full statements
Revenue$34.5mGross margin 5.0%
Diluted EPS−$0.72, Q3 FY2026
Free cash flow−$1.7m, Q4 FY2026
Natural Alternatives International Inc, key figures for the last eight quarters
Line itemUnitQ1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30Shape over the periods
Revenue$m33.2Revenue, Q1 FY2025, three months to 2024-09-30$33.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Report this figure34.1Revenue, Q2 FY2025, three months to 2024-12-31$34.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Report this figure28.8Revenue, Q3 FY2025, three months to 2025-03-31$28.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Report this figure33.9Revenue, Q4 FY2025, three months to 2025-06-30$33.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figure37.7Revenue, Q1 FY2026, three months to 2025-09-30$37.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Report this figure34.8Revenue, Q2 FY2026, three months to 2025-12-31$34.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Report this figure35.5Revenue, Q3 FY2026, three months to 2026-03-31$35.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Report this figure34.5Revenue, Q4 FY2026, three months to 2026-06-30$34.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figure
Gross margin%6.8%Gross margin, Q1 FY2025, three months to 2024-09-30. gross profit / revenueGross profit: $2.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Revenue: $33.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Report this figure4.9%Gross margin, Q2 FY2025, three months to 2024-12-31. gross profit / revenueGross profit: $1.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Revenue: $34.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Report this figure6.3%Gross margin, Q3 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $1.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Revenue: $28.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Report this figure10.4%Gross margin, Q4 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $3.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Revenue: $33.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figure11.7%Gross margin, Q1 FY2026, three months to 2025-09-30. gross profit / revenueGross profit: $4.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Revenue: $37.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Report this figure7.2%Gross margin, Q2 FY2026, three months to 2025-12-31. gross profit / revenueGross profit: $2.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Revenue: $34.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Report this figure1.1%Gross margin, Q3 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $383.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Revenue: $35.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Report this figure5.0%Gross margin, Q4 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $1.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Revenue: $34.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figure
Operating margin%(5.5%)Operating margin, Q1 FY2025, three months to 2024-09-30. operating income / revenueOperating income: −$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Revenue: $33.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Report this figure(8.2%)Operating margin, Q2 FY2025, three months to 2024-12-31. operating income / revenueOperating income: −$2.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Revenue: $34.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Report this figure(7.3%)Operating margin, Q3 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Revenue: $28.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Report this figure(5.7%)Operating margin, Q4 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Revenue: $33.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figure0.8%Operating margin, Q1 FY2026, three months to 2025-09-30. operating income / revenueOperating income: $284.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Revenue: $37.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Report this figure(5.3%)Operating margin, Q2 FY2026, three months to 2025-12-31. operating income / revenueOperating income: −$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Revenue: $34.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Report this figure(11.3%)Operating margin, Q3 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Revenue: $35.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Report this figure(38.2%)Operating margin, Q4 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$13.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Revenue: $34.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figure
Net margin%(6.0%)Net margin, Q1 FY2025, three months to 2024-09-30. net income / revenueNet income: −$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Revenue: $33.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Report this figure(6.4%)Net margin, Q2 FY2025, three months to 2024-12-31. net income / revenueNet income: −$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Revenue: $34.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Report this figure(7.6%)Net margin, Q3 FY2025, three months to 2025-03-31. net income / revenueNet income: −$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Revenue: $28.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Report this figure(21.3%)Net margin, Q4 FY2025, three months to 2025-06-30. net income / revenueNet income: −$7.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Revenue: $33.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figure(0.8%)Net margin, Q1 FY2026, three months to 2025-09-30. net income / revenueNet income: −$291.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Revenue: $37.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Report this figure(7.3%)Net margin, Q2 FY2026, three months to 2025-12-31. net income / revenueNet income: −$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Revenue: $34.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Report this figure(12.1%)Net margin, Q3 FY2026, three months to 2026-03-31. net income / revenueNet income: −$4.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Revenue: $35.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Report this figure(39.2%)Net margin, Q4 FY2026, three months to 2026-06-30. net income / revenueNet income: −$13.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Revenue: $34.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figure
Diluted EPS$ per share(0.33)Diluted EPS, Q1 FY2025, three months to 2024-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Report this figure(0.37)Diluted EPS, Q2 FY2025, three months to 2024-12-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Report this figure(0.37)Diluted EPS, Q3 FY2025, three months to 2025-03-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Report this figurenot reported (Diluted EPS not reported)(0.05)Diluted EPS, Q1 FY2026, three months to 2025-09-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Report this figure(0.42)Diluted EPS, Q2 FY2026, three months to 2025-12-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-13, accession 0001437749-26-004118.Report this figure(0.72)Diluted EPS, Q3 FY2026, three months to 2026-03-31−$0.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-19, accession 0001437749-26-017684.Report this figurenot reported (Diluted EPS not reported)
Free cash flow$m(3.7)Free cash flow, Q1 FY2025, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Capital expenditure: $301.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Report this figure(1.0)Free cash flow, Q2 FY2025, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $37.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-13, accession 0001437749-26-004118. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-13, accession 0001437749-26-004118. Derived: 6-month figure less the 3-month figure.Report this figure5.2Free cash flow, Q3 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-19, accession 0001437749-26-017684. Derived: 9-month figure less the 6-month figure.Capital expenditure: $802.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-19, accession 0001437749-26-017684. Derived: 9-month figure less the 6-month figure.Report this figure1.9Free cash flow, Q4 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $3.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Capital expenditure: $1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figure(5.1)Free cash flow, Q1 FY2026, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Capital expenditure: $1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001437749-25-034473.Report this figure(7.3)Free cash flow, Q2 FY2026, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$6.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-13, accession 0001437749-26-004118. Derived: 6-month figure less the 3-month figure.Capital expenditure: $934.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-13, accession 0001437749-26-004118. Derived: 6-month figure less the 3-month figure.Report this figure1.4Free cash flow, Q3 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-19, accession 0001437749-26-017684. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-19, accession 0001437749-26-017684. Derived: 9-month figure less the 6-month figure.Report this figure(1.7)Free cash flow, Q4 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Capital expenditure: $637.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-09-28, accession 0001437749-26-031343. Derived: 12-month figure less the 9-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$142.5mGross margin 6.3%
Diluted EPS−$3.43, FY2026
Free cash flow−$12.6m, FY2026
Natural Alternatives International Inc, key figures for the last five fiscal years
Line itemUnitFY20222022-06-30FY20232023-06-30FY20242024-06-30FY20252025-06-30FY20262026-06-30Shape over the periods
Revenue$m171Revenue, FY2022, twelve months to 2022-06-30$171.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2023-09-21, accession 0001437749-23-026521.Report this figure154Revenue, FY2023, twelve months to 2023-06-30$154.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-09-27, accession 0001437749-24-030208.Report this figure114Revenue, FY2024, twelve months to 2024-06-30$113.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-09-23, accession 0001437749-25-029731.Report this figure130Revenue, FY2025, twelve months to 2025-06-30$129.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343.Report this figure143Revenue, FY2026, twelve months to 2026-06-30$142.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343.Report this figure
Gross margin%17.8%Gross margin, FY2022, twelve months to 2022-06-30. gross profit / revenueGross profit: $30.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-09-21, accession 0001437749-23-026521.Revenue: $171.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2023-09-21, accession 0001437749-23-026521.Report this figure11.8%Gross margin, FY2023, twelve months to 2023-06-30. gross profit / revenueGross profit: $18.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-09-27, accession 0001437749-24-030208.Revenue: $154.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-09-27, accession 0001437749-24-030208.Report this figure6.0%Gross margin, FY2024, twelve months to 2024-06-30. gross profit / revenueGross profit: $6.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-09-23, accession 0001437749-25-029731.Revenue: $113.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-09-23, accession 0001437749-25-029731.Report this figure7.2%Gross margin, FY2025, twelve months to 2025-06-30. gross profit / revenueGross profit: $9.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-09-28, accession 0001437749-26-031343.Revenue: $129.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343.Report this figure6.3%Gross margin, FY2026, twelve months to 2026-06-30. gross profit / revenueGross profit: $9.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-09-28, accession 0001437749-26-031343.Revenue: $142.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343.Report this figure
Operating margin%8.0%Operating margin, FY2022, twelve months to 2022-06-30. operating income / revenueOperating income: $13.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-09-21, accession 0001437749-23-026521.Revenue: $171.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2023-09-21, accession 0001437749-23-026521.Report this figure3.1%Operating margin, FY2023, twelve months to 2023-06-30. operating income / revenueOperating income: $4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-09-27, accession 0001437749-24-030208.Revenue: $154.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-09-27, accession 0001437749-24-030208.Report this figure(7.5%)Operating margin, FY2024, twelve months to 2024-06-30. operating income / revenueOperating income: −$8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-09-23, accession 0001437749-25-029731.Revenue: $113.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-09-23, accession 0001437749-25-029731.Report this figure(6.7%)Operating margin, FY2025, twelve months to 2025-06-30. operating income / revenueOperating income: −$8.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-28, accession 0001437749-26-031343.Revenue: $129.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343.Report this figure(13.2%)Operating margin, FY2026, twelve months to 2026-06-30. operating income / revenueOperating income: −$18.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-28, accession 0001437749-26-031343.Revenue: $142.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343.Report this figure
Net margin%6.3%Net margin, FY2022, twelve months to 2022-06-30. net income / revenueNet income: $10.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-09-21, accession 0001437749-23-026521.Revenue: $171.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2023-09-21, accession 0001437749-23-026521.Report this figure1.6%Net margin, FY2023, twelve months to 2023-06-30. net income / revenueNet income: $2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-09-27, accession 0001437749-24-030208.Revenue: $154.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-09-27, accession 0001437749-24-030208.Report this figure(6.3%)Net margin, FY2024, twelve months to 2024-06-30. net income / revenueNet income: −$7.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-09-23, accession 0001437749-25-029731.Revenue: $113.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-09-23, accession 0001437749-25-029731.Report this figure(10.5%)Net margin, FY2025, twelve months to 2025-06-30. net income / revenueNet income: −$13.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-28, accession 0001437749-26-031343.Revenue: $129.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343.Report this figure(14.5%)Net margin, FY2026, twelve months to 2026-06-30. net income / revenueNet income: −$20.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-28, accession 0001437749-26-031343.Revenue: $142.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-09-28, accession 0001437749-26-031343.Report this figure
Diluted EPS$ per share1.74Diluted EPS, FY2022, twelve months to 2022-06-30$1.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-09-21, accession 0001437749-23-026521.Report this figure0.43Diluted EPS, FY2023, twelve months to 2023-06-30$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-09-27, accession 0001437749-24-030208.Report this figure(1.23)Diluted EPS, FY2024, twelve months to 2024-06-30−$1.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-09-23, accession 0001437749-25-029731.Report this figure(2.28)Diluted EPS, FY2025, twelve months to 2025-06-30−$2.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-09-28, accession 0001437749-26-031343.Report this figure(3.43)Diluted EPS, FY2026, twelve months to 2026-06-30−$3.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-09-28, accession 0001437749-26-031343.Report this figure
Free cash flow$m(14.6)Free cash flow, FY2022, twelve months to 2022-06-30. operating cash flow − capital expenditureOperating cash flow: $11.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-09-21, accession 0001437749-23-026521.Capital expenditure: $26.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-09-21, accession 0001437749-23-026521.Report this figure(6.5)Free cash flow, FY2023, twelve months to 2023-06-30. operating cash flow − capital expenditureOperating cash flow: $7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-09-27, accession 0001437749-24-030208.Capital expenditure: $13.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-09-27, accession 0001437749-24-030208.Report this figure(4.5)Free cash flow, FY2024, twelve months to 2024-06-30. operating cash flow − capital expenditureOperating cash flow: −$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-09-23, accession 0001437749-25-029731.Capital expenditure: $3.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-09-23, accession 0001437749-25-029731.Report this figure2.3Free cash flow, FY2025, twelve months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $5.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-28, accession 0001437749-26-031343.Capital expenditure: $3.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-09-28, accession 0001437749-26-031343.Report this figure(12.6)Free cash flow, FY2026, twelve months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$8.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-28, accession 0001437749-26-031343.Capital expenditure: $3.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-09-28, accession 0001437749-26-031343.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Natural Alternatives International Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
CALDWELL SUTTER CAPITAL, INC.2026-06-30$1.2m498,220Reduced−572
DIMENSIONAL FUND ADVISORS LP2026-06-30$802.5k335,789Reduced−18,950
MORGAN STANLEY2026-06-30$735.2k307,630Added+39,380
Mink Brook Asset Management LLC2026-06-30$701.3k293,447Reduced−262
RENAISSANCE TECHNOLOGIES LLC2026-06-30$663.1k277,457Reduced−13,899
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$504.0k210,880Unchanged
Integrated Wealth Concepts LLC2026-06-30$210.8k88,186Added+76,186
CITADEL ADVISORS LLC2026-06-30$181.0k75,746Added+32,038
BRIDGEWAY CAPITAL MANAGEMENT, LLC2026-06-30$147.0k61,495Reduced−13,821
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$104.5k43,711Reduced−8,694

Recent filings

All 478 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Natural Alternatives International Inc, recent filings
FiledFormWhat it isAccession number
2026-10-2316:11 ETDEF 14AProxy statementPeriod 2026-12-110001437749-26-033415
2026-09-2816:16 ET10-KAnnual reportPeriod 2026-06-300001437749-26-031343
2026-05-1906:03 ET10-QQuarterly reportPeriod 2026-03-310001437749-26-017684
2026-05-0117:00 ET8-K5.02 Departure or appointment of officers or directors0001437749-26-014497
2026-03-2016:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001437749-26-009247
2026-02-1316:17 ET10-QQuarterly reportPeriod 2025-12-310001437749-26-004118
2025-12-1717:13 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001437749-25-038181
2025-12-1220:10 ET8-K5.07 Shareholder vote results0001437749-25-037601
2025-11-1216:35 ET10-QQuarterly reportPeriod 2025-09-300001437749-25-034473
2025-10-2316:16 ETDEF 14AProxy statementPeriod 2025-12-050001437749-25-031627

Latest annual report

Form 10-K for the fiscal year ended Jun 30, 2026Filed Sep 28, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q1 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
787253
Tickers
NAII
Exchange
Nasdaq
SIC code
2833 Medicinal Chemicals & Botanical Products
Sector
Healthcare
Fiscal year ends
Jun 30
Incorporated in
DE
Filer category
Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:24 ET. Listed shows no prices and gives no investment advice.